Procalcitonin Testing in Community-Acquired Pneumonia

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate the effectiveness of procalcitonin testing in diagnosing community-acquired pneumonia.
Study design
Participants diagnosed with community-acquired pneumonia
Utilized procalcitonin as a biomarker for diagnosis
Procalcitonin testing significantly improved diagnostic accuracy compared to standard methods, with a diagnostic accuracy of 85% (95% CI, 75%-95%) and p<0.01.
Patients receiving procalcitonin-guided treatment showed a reduced need for antibiotic therapy, leading to a 25% decrease in prescriptions.
The time to diagnosis was reduced by 24 hours, improving patient outcomes.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Shows improved diagnostic accuracy of procalcitonin testing in community-acquired pneumonia, suggesting better patient management.

No takes yet. Share an insight, caveat, or question.

Deshpande et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share